Entradas

Mostrando entradas de noviembre, 2019

Capítulo B01. Tree pollen allergy. Jueves 28 de noviembre

Capítulo B01.  Tree pollen allergy. Authors:   Enrico Scala, Riccardo Asero, Verena  Niederberger                                            Abstract   Cup a 1 reactivity is the specific marker  allergen for a sensitization to the Cupressaceae family.  PR-10 molecules (i.e. Bet v 1) are the major  allergens in Fagales pollen, often associated  with an oral allergy syndrome.  Ole e 1 is the most common sensitizing molecule in olive pollen.  Pla a 1 and Pla a 2 may serve as a marker of  primary sensitization to plane tree pollen. EAACI link:  www.eaaci.org

Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study.Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study. Miércoles 27 de noviembre

Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study. Authors: Soriano VX1, Peters RL1, Ponsonby AL2, Dharmage SC3, Perrett KP4, Field MJ5, Knox A5, Tey D6, Odoi S5, Gell G5, Camesella Perez B5, Allen KJ7, Gurrin LC8, Koplin JJ9. 1Murdoch Children's Research Institute, Parkville, Australia; Department of Paediatrics, University of Melbourne, Parkville, Australia. 2School of Population and Global Health, University of Melbourne, Parkville, Australia; Neuroepidemiology Research Group, Florey Institute for Neuroscience and Mental Health, Parkville, Australia. 3School of Population and Global Health, University of Melbourne, Parkville, Australia. 4Murdoch Children's Research Institute, Parkville, Australia; Department of Allergy and Immunology, Royal Children's Hospital, Parkville, Australia; School of Population and Global Health, University of Melbourne, Parkville, Australia. 5Murdoch Children's Research Institute, Parkville,

S3 guidelines: Epicutaneous patch testing with contact allergens and drugs - Short version, Part 1. Martes 26 de noviembre

S3 guidelines: Epicutaneous patch testing with contact allergens and drugs - Short version, Part 1. Authors: Mahler V1,2, Nast A3, Bauer A4, Becker D5, Brasch J6, Breuer K7, Dickel H8, Drexler H9, Elsner P10, Geier J11, John SM12, Kreft B13, Köllner A14, Merk H15, Ott H16, Pleschka S17, Portisch M1, Spornraft-Ragaller P4, Weisshaar E18, Werfel T19, Worm M20, Schnuch A11, Uter W21. Author information 1 Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. 2 Paul-Ehrlich-Institut, Langen, Germany. 3 Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt University of Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergology, Division of Evidence-based Medicine (dEBM), Berlin, Germany. 4 Department of Dermatology, University Medical Center, Dresden Technical University, Dresden, Germany. 5 Department of Dermatology, University Medica

Sulfonamide Drug Allergy. Lunes 15 de noviembre

Sulfonamide Drug Allergy. Authors: Dorn JM1, Alpern M1, McNulty C1, Volcheck GW2. 1 Mayo Clinic, Division of Allergic Diseases, 200 First Street SW, Rochester, MN, 55905, USA. 2 Mayo Clinic, Division of Allergic Diseases, 200 First Street SW, Rochester, MN, 55905, USA. Volcheck.gerald@mayo.edu. Abstract PURPOSE OF REVIEW: We sought to review past and current literature on sulfonamide drug allergy and distill it in a practical manner to assist the clinician, specifically focusing on cross-reactivity and desensitization. RECENT FINDINGS: There do not appear to be consistent genetic markers to reliably predict features of or the presence hypersensitivity reactions. Recent evidence continues to alleviate early concerns cross-reactivity between sulfonamide antibiotics and non-antibiotics. Sulfonamide drug allergy is frequently encountered by the practicing clinician. For sulfonamide antibiotics, delayed rash is the most common clinical manifestation. There is no current evid

Nutritional Issues in Food Allergy. Miércoles 20 de noviembre

Nutritional Issues in Food Allergy. Authors: Skypala IJ1,2, McKenzie R3. 1 Royal Brompton and Harefield NHS Foundation Trust, London, UK. i.skypala@rbht.nhs.uk. 2 Imperial College, London, UK. i.skypala@rbht.nhs.uk. 3 Imperial College Healthcare NHS Trust, London, UK. Abstract Diet and nutrition play an important role in the development and management of food allergy. The diet of expectant mothers can have an effect on their offspring in terms of allergic outcomes. A host of confounding factors may influence this, with a maternal diet rich in fruits and vegetables, fish, vitamin D-rich foods associated with a lower risk of allergic disease in their children. More surprisingly, the consumption of milk and butter has also been shown to have a protective effect, especially in a farm environment. Similarly, the diet of the infant can also be important, not only in terms of breast feeding, but also the timing of the introduction of complementary foods, the diversity o

Current and emerging treatments for chronic spontaneous urticaria. Martes 19 de noviembre.

Current and emerging treatments for chronic spontaneous urticaria. Authors: Johal KJ1, Saini SS2. 1 Johns Hopkins Asthma and Allergy Center, Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2 Johns Hopkins Asthma and Allergy Center, Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: ssaini@jhmi.edu. Abstract OBJECTIVES: To review the published literature on current and new treatments for chronic spontaneous urticaria (CSU) and to provide guidance on the potential use of these therapeutics. DATA SOURCES: A PubMed search was performed to include English-language articles with the keywords chronic spontaneous urticaria, pathophysiology, quality of life, and treatments, with a preference to those articles written in the last 5 years. ClinicalTrials.gov was reviewed for recent rele

Update on Quinolone Allergy. Lunes 18 de noviembre.

Update on Quinolone Allergy. Authors: Doña I1, Moreno E2,3, Pérez-Sánchez N4, Andreu I5, Hernández Fernandez de Rojas D6, Torres MJ4. 1 Allergy Unit, Pabellón 6, primera planta, IBIMA Regional University Hospital of Malaga-UMA (Pavillion C, Hospital Civil), Plaza del Hospital Civil, 29009, Malaga, Spain. inmadd@hotmail.com. 2 Allergy Service, University Hospital of Salamanca, Salamanca, Spain. 3 Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. 4 Allergy Unit, Pabellón 6, primera planta, IBIMA Regional University Hospital of Malaga-UMA (Pavillion C, Hospital Civil), Plaza del Hospital Civil, 29009, Malaga, Spain. 5 Unidad Mixta de Investigación IIS La Fe-UniversitatPolitècnica de València, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026, Valencia, Spain. 6 Department of Allergy, Hospital Universitari i Politècnic La Fe, Valencia, Spain. Abstract PURPOSE OF REVIEW: Quinolones are a gr

Curso de Alergología Molecular.

Imagen
Dr. Ricardo Cardona Villa, Jefe del Programa de Alergología Clínica, en compañía de otros 7 docentes y 7 de los residentes del programa. "Este programa nutre y oxigena la Alergología Clínica en Colombia" Ricardo Cardona Villa.

Capítulo A6. Allergen families and databases. Jueves 14 de noviembre

Capítulo A6.  Allergen families and databases. Authors:   Heimo Breiteneder                                            Abstract   Proteins that share a common evolutionary origin - which is reflected first and foremost by their similar overall structure and topology - are grouped into families. Families with a common origin are grouped into superfamilies. Very few of the almost 16,300 protein families as described by the protein family database Pfam families harbour allergens. Proteins that are described worldwide as allergens can be classified roughly into 30 to 40 protein families. Based on their molecular, biologic and biochemical properties, allergenic proteins are able to initiate both innate and adaptive immune responses during the sensitization process that ultimately result in the production of allergen-specific IgE. Allergen databases make curated information available on the allergen nomenclature, allergen structures, allergen protein families, and the

Current Trends in Tolerance Induction in Cow's Milk Allergy: From Passive to Proactive Strategies. Miércoles 13 de noviembre

Current Trends in Tolerance Induction in Cow's Milk Allergy: From Passive to Proactive Strategies. Authors: Sackesen C1, Altintas DU2, Bingol A3, Bingol G4, Buyuktiryaki B5, Demir E6, Kansu A7, Kuloglu Z7, Tamay Z8, Sekerel BE5. 1Division of Pediatric Allergy, Department of Pediatrics, Koc University School of Medicine, Istanbul, Turkey. 2Division of Pediatric Allergy, Department of Pediatrics, Cukurova University School of Medicine, Adana, Turkey. 3Division of Pediatric Allergy and Immunology, Department of Pediatrics, Akdeniz University Faculty of Medicine, Antalya, Turkey. 4Division of Pediatric Allergy and Immunology, Department of Pediatrics, Acibadem University School of Medicine, Istanbul, Turkey. 5Division of Pediatric Allergy and Asthma, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. 6Division of Pediatric Allergy, Department of Pediatrics, Ege University School of Medicine, Izmir, Turkey. 7Division of Pediatr

Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Martes 12 de noviembre

Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Authors: Bonadonna P1, Pagani M2, Aberer W3, Bilò MB4, Brockow K5, Oude Elberink H6, Garvey L7, Mosbech H7, Romano A8, Zanotti R9, Torres MJ10. 1Allergy Unit, Azienda Ospedaliera Universitaria Intergrata of Verona, Verona, Italy. 2Medicine Ward, Pieve di Coriano Hospital Azienda Ospedaliera Carlo Poma Mantova, Mantova, Italy. 3Department of Dermatology and Venerology, Medizinische Universitat Graz, Graz, Austria. 4Allergy Unit, Department of Internal Medicine, Ospedali Riuniti di Ancona, Ancona, Italy. 5Department of Dermatology and Allergy Biederstein, Technische Universität München, Munich, Germany. 6Department of Allergology, GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 7Allergy Clinic, Copenhagen University Hospital, Gentofte, Denmark. 8Allergy Unit Complesso Integrato Columbus, Rome and IRCCS Oasi Maria S.

Capítulo A5.Skin test, basophil activation test (bat) and provocation tests Jueves 7 de noviembre

Capítulo A5. Skin test, basophil activation test (bat) and provocation tests Authors:   Nikos Douladiris, Peter Korosec, Hans Jürgen Hoffmann                                            Abstract   Skin and other provocation testing with molecular allergens is safe and may provide important information beyond extract testing. Basophil activation testing of molecular allergens is a good alternative prior to skin or other provocation testing. EAACI link:  www.eaaci.org

Food Intolerances. Miércoles 6 de noviembre

Food Intolerances Authors: Tuck CJ1,2, Biesiekierski JR2, Schmid-Grendelmeier P3, Pohl D4 . 1 Gastrointestinal Diseases Research Unit, Queen's University, Kingston, ON K7L 2V7, Canada. 2 Department of Dietetics, Nutrition and Sport, La Trobe University, Melbourne 3086, Australia. 3 Allergy Unit, Department of Dermatology, University Hospital Zurich, 8091 Zurich Switzerland and Christine-Kühne Center for Allergy Research and Education CK-CARE, 7265 Davos, Switzerland. 4 Department of Gastroenterology, University Hospital Zurich, 8091 Zurich, Switzerland. daniel.pohl@usz.ch. Abstract Food intolerances are estimated to affect up to 20% of the population but complete understanding of diagnosis and management is complicated, given presentation and non-immunological mechanisms associated vary greatly. This review aims to provide a scientific update on common food intolerances resulting in gastrointestinal and/or extra-intestinal symptoms. FODMAP sensitivity has strong evidenc

Cardiac safety of second-generation H1-antihistamines when updosed in chronic urticaria. Martes 5 de noviembre

Cardiac safety of second-generation H1-antihistamines when updosed in chronic urticaria. Authors Cataldi M1, Maurer M2, Taglialatela M1, Church MK2 . 1 Section of Pharmacology, Department of Neuroscience, School of Medicine, University of Naples Federico II, Naples, Italy. 2 Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany. Abstract The symptoms of chronic urticaria, be it chronic spontaneous urticaria (CSU) or chronic inducible urticaria (CindU), are mediated primarily by the actions of histamine on H1 receptors located on endothelial cells (the weal) and on sensory nerves (neurogenic flare and pruritus). Thus, second-generation H1 antihistamines (sgAHs) are the primary treatment of these conditions. However, many patients are poorly responsive to licensed doses of antihistamines. In these patients, the current EAACI/GA2 LEN/EDF/WAO guideline for urticaria suggests updosing of sg